Peptide Therapy · CJC-1295 / Ipamorelin
CJC-1295 / Ipamorelin Therapy
CJC-1295 and ipamorelin are growth-hormone-supporting peptides used together. CJC-1295 extends the signal; ipamorelin prompts a clean pulse of growth hormone with a relatively favorable profile.
Paired, they're intended to work with your body's natural, pulsatile rhythm — which is why this combination is one of the most commonly used in peptide therapy.
We measure first. Then we act.
What this pairing may help support
An honest word on the evidence
Who it's for
How it works at ACT 2 Health
Every plan follows one path. Each step feeds the next. See the Peptide Therapy approach.
- 01
Measure
A baseline of labs and history, and a clear read on your goals.
- 02
Plan
A clinician decides whether it fits — and what to address first.
- 03
Act
If appropriate, you begin with clear guidance and support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Frequently asked questions
They complement each other — CJC-1295 extends the growth-hormone signal while ipamorelin triggers a clean pulse, working with your natural rhythm.
No. These peptides support your body's own growth-hormone release rather than supplying hormone directly.
We only consider it for eligible patients under clinical evaluation and monitoring, and we're candid about the limits of the evidence.
Results vary and build over time. We track your response on a defined cadence.
Ready to start with clarity?
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.